• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估在药物选择压力下HIV-1所经历的体内适应性景观,这对于预测治疗期间耐药性的演变很有用。

Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment.

作者信息

Deforche K, Camacho R, Van Laethem K, Lemey P, Rambaut A, Moreau Y, Vandamme A-M

机构信息

Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium.

出版信息

Bioinformatics. 2008 Jan 1;24(1):34-41. doi: 10.1093/bioinformatics/btm540. Epub 2007 Nov 17.

DOI:10.1093/bioinformatics/btm540
PMID:18024973
Abstract

MOTIVATION

HIV-1 antiviral resistance is a major cause of antiviral treatment failure. The in vivo fitness landscape experienced by the virus in presence of treatment could in principle be used to determine both the susceptibility of the virus to the treatment and the genetic barrier to resistance. We propose a method to estimate this fitness landscape from cross-sectional clinical genetic sequence data of different subtypes, by reverse engineering the required selective pressure for HIV-1 sequences obtained from treatment naive patients, to evolve towards sequences obtained from treated patients. The method was evaluated for recovering 10 random fictive selective pressures in simulation experiments, and for modeling the selective pressure under treatment with the protease inhibitor nelfinavir.

RESULTS

The estimated fitness function under nelfinavir treatment considered fitness contributions of 114 mutations at 48 sites. Estimated fitness correlated significantly with the in vitro resistance phenotype in 519 matched genotype-phenotype pairs (R(2) = 0.47 (0.41 - 0.54)) and variation in predicted evolution under nelfinavir selective pressure correlated significantly with observed in vivo evolution during nelfinavir treatment for 39 mutations (with FDR = 0.05).

AVAILABILITY

The software is available on request from the authors, and data sets are available from http://jose.med.kuleuven.be/~kdforc0/nfv-fitness-data/.

摘要

动机

HIV-1抗病毒耐药性是抗病毒治疗失败的主要原因。原则上,病毒在治疗过程中所经历的体内适应性景观可用于确定病毒对治疗的敏感性以及耐药性的遗传屏障。我们提出了一种方法,通过对从未经治疗的患者获得的HIV-1序列逆向工程所需的选择压力,使其向从接受治疗的患者获得的序列进化,从而从不同亚型的横断面临床基因序列数据中估计这种适应性景观。该方法在模拟实验中评估了恢复10种随机虚拟选择压力的能力,并用于模拟蛋白酶抑制剂奈非那韦治疗下的选择压力。

结果

奈非那韦治疗下估计的适应性函数考虑了48个位点处114个突变的适应性贡献。在519对匹配的基因型-表型对中,估计的适应性与体外耐药表型显著相关(R(2)=0.47(0.41 - 0.54)),并且在奈非那韦选择压力下预测进化的变化与奈非那韦治疗期间39个突变的体内观察进化显著相关(FDR = 0.05)。

可用性

该软件可根据作者要求提供,数据集可从http://jose.med.kuleuven.be/~kdforc0/nfv-fitness-data/获取。

相似文献

1
Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment.评估在药物选择压力下HIV-1所经历的体内适应性景观,这对于预测治疗期间耐药性的演变很有用。
Bioinformatics. 2008 Jan 1;24(1):34-41. doi: 10.1093/bioinformatics/btm540. Epub 2007 Nov 17.
2
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.在药物选择压力下模拟的体内HIV适应性以及对耐药性的估计遗传屏障可预测病毒学反应。
Antivir Ther. 2008;13(3):399-407.
3
A model of directional selection applied to the evolution of drug resistance in HIV-1.一种应用于HIV-1耐药性进化的定向选择模型。
Mol Biol Evol. 2007 Apr;24(4):1025-31. doi: 10.1093/molbev/msm021. Epub 2007 Feb 1.
4
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure.利用纵向序列数据中观察到的进化,建立用于评估茚地那韦治疗压力下的 HIV-1 适应性景观模型,可预测治疗失败。
Infect Genet Evol. 2013 Oct;19:349-60. doi: 10.1016/j.meegid.2013.03.014. Epub 2013 Mar 21.
5
Estimating HIV evolutionary pathways and the genetic barrier to drug resistance.估计HIV的进化途径和耐药性的遗传屏障。
J Infect Dis. 2005 Jun 1;191(11):1953-60. doi: 10.1086/430005. Epub 2005 Apr 28.
6
Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations.结合横断面数据和前瞻性数据方法,以改进用于表征HIV-1耐药性突变积累的转换参数估计。
Biometrics. 2007 Sep;63(3):742-50. doi: 10.1111/j.1541-0420.2007.00774.x. Epub 2007 Apr 2.
7
Characterization and structural analysis of HIV-1 integrase conservation.HIV-1整合酶保守性的表征与结构分析
AIDS Rev. 2009 Jan-Mar;11(1):17-29.
8
Drug induced superinfection in HIV and the evolution of drug resistance.HIV 中的药物诱导二重感染与耐药性演变
Infect Genet Evol. 2008 Jan;8(1):40-50. doi: 10.1016/j.meegid.2007.09.008. Epub 2007 Sep 29.
9
Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.在CONTEXT和TRIAD临床试验中,对蛋白酶抑制剂经治患者使用福沙那韦-利托那韦的病毒学反应进行基因型耐药性分析。
Antimicrob Agents Chemother. 2008 Dec;52(12):4251-7. doi: 10.1128/AAC.00514-08. Epub 2008 Oct 13.
10
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.HIV-1逆转录酶抑制剂耐药性突变与适应性:临床及体外研究视角
Virus Res. 2008 Jun;134(1-2):104-23. doi: 10.1016/j.virusres.2007.12.021. Epub 2008 Mar 4.

引用本文的文献

1
Inference of clonal selection in cancer populations using single-cell sequencing data.利用单细胞测序数据推断癌症群体中的克隆选择。
Bioinformatics. 2019 Jul 15;35(14):i398-i407. doi: 10.1093/bioinformatics/btz392.
2
From hype to reality: data science enabling personalized medicine.从炒作到现实:数据科学推动个性化医疗。
BMC Med. 2018 Aug 27;16(1):150. doi: 10.1186/s12916-018-1122-7.
3
A framework for inferring fitness landscapes of patient-derived viruses using quasispecies theory.一种使用准种理论推断患者源病毒适应性景观的框架。
Genetics. 2015 Jan;199(1):191-203. doi: 10.1534/genetics.114.172312. Epub 2014 Nov 17.
4
Realistic three dimensional fitness landscapes generated by self organizing maps for the analysis of experimental HIV-1 evolution.用于分析实验性HIV-1进化的自组织映射生成的逼真三维适应性景观。
PLoS One. 2014 Feb 28;9(2):e88579. doi: 10.1371/journal.pone.0088579. eCollection 2014.
5
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.个体化遗传屏障可预测大量 HIV-1 感染患者的治疗反应。
PLoS Comput Biol. 2013;9(8):e1003203. doi: 10.1371/journal.pcbi.1003203. Epub 2013 Aug 29.
6
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients.新诊断为未经药物治疗的 HIV-1 感染患者中,蛋白酶相关的治疗相关多态性与较高的病毒载量和较低的 CD4 计数显著相关。
Retrovirology. 2012 Oct 3;9:81. doi: 10.1186/1742-4690-9-81.
7
Commentary on the role of treatment-related HIV compensatory mutations on increasing virulence: new discoveries twenty years since the clinical testing of protease inhibitors to block HIV-1 replication.关于治疗相关的 HIV 补偿性突变在增加病毒毒力方面的作用的述评:自临床检测蛋白酶抑制剂抑制 HIV-1 复制以来 20 年的新发现。
BMC Med. 2012 Oct 3;10:114. doi: 10.1186/1741-7015-10-114.
8
Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem.基于结构的方法预测靶突变诱导的药物耐药性和克服该问题的合理药物设计。
Drug Discov Today. 2012 Oct;17(19-20):1121-6. doi: 10.1016/j.drudis.2012.06.018. Epub 2012 Jul 10.
9
Bringing molecules back into molecular evolution.将分子带回分子进化中。
PLoS Comput Biol. 2012;8(6):e1002572. doi: 10.1371/journal.pcbi.1002572. Epub 2012 Jun 28.
10
Exploring the complexity of the HIV-1 fitness landscape.探索 HIV-1 适应性景观的复杂性。
PLoS Genet. 2012;8(3):e1002551. doi: 10.1371/journal.pgen.1002551. Epub 2012 Mar 8.